GB0204087D0 - Di-ester derivatives as short acting neuromuscular blockers - Google Patents

Di-ester derivatives as short acting neuromuscular blockers

Info

Publication number
GB0204087D0
GB0204087D0 GBGB0204087.1A GB0204087A GB0204087D0 GB 0204087 D0 GB0204087 D0 GB 0204087D0 GB 0204087 A GB0204087 A GB 0204087A GB 0204087 D0 GB0204087 D0 GB 0204087D0
Authority
GB
United Kingdom
Prior art keywords
ester derivatives
short acting
neuromuscular blockers
acting neuromuscular
blockers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0204087.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therasci Ltd
Original Assignee
Legislator 1563 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Legislator 1563 Ltd filed Critical Legislator 1563 Ltd
Priority to GBGB0204087.1A priority Critical patent/GB0204087D0/en
Publication of GB0204087D0 publication Critical patent/GB0204087D0/en
Priority to GB0303850A priority patent/GB2385590A/en
Priority to PCT/GB2003/000713 priority patent/WO2003070243A1/en
Priority to AU2003207328A priority patent/AU2003207328A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
GBGB0204087.1A 2002-02-21 2002-02-21 Di-ester derivatives as short acting neuromuscular blockers Ceased GB0204087D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0204087.1A GB0204087D0 (en) 2002-02-21 2002-02-21 Di-ester derivatives as short acting neuromuscular blockers
GB0303850A GB2385590A (en) 2002-02-21 2003-02-19 New diester guanidine or diester quaternised N-containing compounds
PCT/GB2003/000713 WO2003070243A1 (en) 2002-02-21 2003-02-19 Di-ester derivatives as short acting neuromuscular blockers
AU2003207328A AU2003207328A1 (en) 2002-02-21 2003-02-19 Di-ester derivatives as short acting neuromuscular blockers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0204087.1A GB0204087D0 (en) 2002-02-21 2002-02-21 Di-ester derivatives as short acting neuromuscular blockers

Publications (1)

Publication Number Publication Date
GB0204087D0 true GB0204087D0 (en) 2002-04-10

Family

ID=9931500

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0204087.1A Ceased GB0204087D0 (en) 2002-02-21 2002-02-21 Di-ester derivatives as short acting neuromuscular blockers
GB0303850A Withdrawn GB2385590A (en) 2002-02-21 2003-02-19 New diester guanidine or diester quaternised N-containing compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0303850A Withdrawn GB2385590A (en) 2002-02-21 2003-02-19 New diester guanidine or diester quaternised N-containing compounds

Country Status (3)

Country Link
AU (1) AU2003207328A1 (en)
GB (2) GB0204087D0 (en)
WO (1) WO2003070243A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9156826B2 (en) 2012-06-29 2015-10-13 Cornell University Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration
CN110776481B (en) * 2018-07-24 2023-06-16 四川大学华西医院 Biscationic compound, preparation method and application thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT292702B (en) * 1968-12-29 1971-09-10 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of new N-methyl-piperidine derivatives and the acid addition salts and the onium derivatives of these compounds
FR2051494B1 (en) * 1969-04-02 1974-04-12 Taiho Pharmaceutical Co Ltd
US4032531A (en) * 1969-12-03 1977-06-28 The United States Of America As Represented By The Secretary Of The Army Piperidine derivatives
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
US4701460A (en) * 1980-12-17 1987-10-20 Burroughs Wellcome Co. Long duration neuromuscular blocking agents
GB8418303D0 (en) * 1984-07-18 1984-08-22 Wellcome Found Compounds
DE4000551A1 (en) * 1989-01-13 1990-07-19 Ciba Geigy Ag Photochemical stabilisation of dyed wool - by treatment in an aq. bath contg. sterically hindered amine light protection agent
JPH10295785A (en) * 1997-05-02 1998-11-10 Shikoku Kakoki Co Ltd Sterilizing method for bacteria spores
JPH11349819A (en) * 1998-06-03 1999-12-21 Matsushita Electric Ind Co Ltd Stainproofing agent for resin and stainproof resin containing the same
US6251381B1 (en) * 1998-11-04 2001-06-26 Inui Corporation Antibacterial and antifungal resin composition
JP2000159608A (en) * 1998-11-30 2000-06-13 Otsuka Chem Co Ltd Antimicrobial composition
CA2360790A1 (en) * 1999-02-01 2000-08-03 Laszlo Gyermek Mono-acyloxy aralkyl neuromuscular relaxants

Also Published As

Publication number Publication date
GB2385590A (en) 2003-08-27
GB0303850D0 (en) 2003-03-26
AU2003207328A1 (en) 2003-09-09
WO2003070243A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
AP2005003343A0 (en) Substituted pyrrolo-pyrazole derivatives as kinaseinhibitors
HUS1400037I1 (en) Novel 2-pyridylethylbenzamide derivative
ZA200603657B (en) Novel quinoline derivatives
IL169905A0 (en) Novel 2-pyridinecarboxamide derivatives
ZA200500294B (en) Novel 2-pyridylethylbenzamide derivative
AU2003238054A8 (en) Piperidine compounds as antibacterials
SI1551802T1 (en) Indole-3-sulphur derivatives
EP1522540A4 (en) Azaarene derivatives
IL165810A0 (en) Novel benzimidazole derivatives
GB0219896D0 (en) Dihydropyridine derivatives
AU2003295693A8 (en) Improved sunscreen compositions
HK1091204A1 (en) Heteroarylcarbamoylbenzene derivative
PL375220A1 (en) Piperidine derivatives
IL176562A0 (en) Amidopyrazole derivative
EP1511408A4 (en) Cross reference to related art
IL162765A0 (en) Piperidine derivatives
EP1478634A4 (en) Furanone derivatives
PL373697A1 (en) Isoquinoline derivatives
HK1071364A1 (en) Quinoline derivatives
PL371216A1 (en) Isoquinoline derivatives
GB0312368D0 (en) Novel ureido- and amido-pyrazolone derivatives
GB0204087D0 (en) Di-ester derivatives as short acting neuromuscular blockers
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
GB0304901D0 (en) Novel aminopyridine derivatives as mGIuR5 antagonists
AU2003280821A8 (en) Beauveriolide derivative

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)